TMCI NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Treace Medical Concepts Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 4.31 USD
7.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 59.7% above the Trend Line and sits at 47.5% of its 52-week range. The latest completed week returned 7.7%, after a 2.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 37/100 conviction, while the latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 48 out of 100
Latest Close 4.31 USD 31 Jul 2026
1W Return 7.7% latest completed week
4W Return 2.4% short-term follow-through
12W Return 114.4% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • The trend backdrop is active with a 7-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.7% Latest completed week; four-week move 2.4%. Indicator stack 34/68 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 37/100 conviction; expected move 29.4%. News sentiment 47/100 69 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 59.7% above the Trend Line and sits at 47.5% of its 52-week range. The latest completed week returned 7.7%, after a 2.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7812-week average 0.39

12-week confirmation

Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.78Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 2.4% over four weeks, 114.4% over 12 weeks, and -19.3% over one year. The current trend has remained active for 7 consecutive weeks.

Performance by holding period

1W7.7%
4W2.4%
12W114.4%
26W85.8%
52W-19.3%
Active trend streak7 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.12Latest activity-pressure read.
Pressure change-25.6%Four-week change in activity pressure.
Leadership3.94Latest relative-leadership reading.
RS change157.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 80%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength7/100Blend of value, momentum, and quality. Underlying universe rank 94; rank 1 is best.
Value29/100Relative valuation strength. Underlying universe rank 72; rank 1 is best.
Quality12/100Profitability and accounting quality. Underlying universe rank 89; rank 1 is best.
Momentum21/100Medium-term price momentum. Underlying universe rank 80; rank 1 is best.
Growth23/100Revenue and earnings growth. Underlying universe rank 78; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
79.7%
Gross profit retained from each unit of revenue.
Operating margin
-26.8%
Operating profit retained from revenue.
Free-cash-flow margin
0.0%
Free cash flow generated from revenue.
Return on invested capital
-51.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-1.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

TMCI shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of n/a, expected move of 29.4%, and Sharemaestro trend signal active.

Conviction37/100
Expected move29.4%
Put/call volume
Pressure9
Speculation0
Volatility96
Trend agreement93
Open options detail
Insider activity17 / 1

17 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment47/100

Weighted news tone is neutral across 69 relevant articles.

7 positive · 52 neutral · 10 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move29.4%Nearest-chain priced movement where available.
52-week drawdown-44.6%Distance below the 52-week high.
13-week volatility10.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+32.3%Week of 15 May.
Worst week-23.1%Week of 6 Mar.
Latest week+7.7%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains6
Flat weeks0
Modest losses4
Sharp losses6
Recent vol10.8%13-week weekly-return volatility.
Base vol12.2%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew9.4% / -8.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape43/100

Trend, activity pressure, participation, and risk combine to a 43/100 tape read.

 Indicator analysis61/100

Latest 12-week confirmation: trend 7/12, activity pressure 12/12, relative leadership 2/12.

Activity pressure 0.78; No reversal markers Factors15/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 61; Small Cap Core rank 71 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options59/100

TMCI shows mixed options pressure with a 37/100 conviction score, put-call volume ratio of n/a, expected move of 29.4%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 29.4% Sentiment47/100

Weighted news tone is neutral across 69 relevant articles.

Treace Medical Concepts (TMCI) Expected to Post Earnings on Friday Insiders17 / 1

17 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20264.31 USD7.7%2.70 USD7.15 USD1.123.941.5MOn
24 Jul 20264.00 USD-7.0%2.64 USD7.26 USD1.23-4.051.5MOn
17 Jul 20264.30 USD-0.5%2.59 USD7.38 USD1.440.152.4MOn
10 Jul 20264.32 USD2.6%2.53 USD7.51 USD1.48-4.732.7MOn
3 Jul 20264.21 USD-5.6%2.48 USD7.64 USD1.50-6.883.2MOn
26 Jun 20264.46 USD6.4%2.43 USD7.76 USD1.51-2.0611.8MOn
19 Jun 20264.19 USD3.2%2.38 USD7.89 USD1.39-13.224.0MOn
12 Jun 20264.06 USD15.7%2.33 USD8.03 USD1.34-14.883.8MOff
5 Jun 20263.51 USD1.4%2.30 USD8.17 USD1.33-25.833.4MOff
29 May 20263.46 USD24.5%2.33 USD8.31 USD1.24-31.362.1MOff
22 May 20262.78 USD4.5%2.43 USD8.46 USD1.08-44.263.0MOff
15 May 20262.66 USD32.3%2.57 USD8.61 USD0.92-47.154.3MOff
8 May 20262.01 USD8.1%2.69 USD8.76 USD0.73-61.161.9MOff
1 May 20261.86 USD-6.1%2.82 USD8.91 USD0.71-63.171.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.